[Adaptative immunity and pathophysiology of multiple sclerosis].
暂无分享,去创建一个
[1] Andrew K. Sewell,et al. Why must T cells be cross-reactive? , 2012, Nature Reviews Immunology.
[2] D. Laplaud,et al. Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients. , 2012, Clinical immunology.
[3] Bernhard Hemmer,et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. , 2012, The New England journal of medicine.
[4] D. Hafler,et al. Regulatory T cells in the central nervous system , 2012, Immunological reviews.
[5] H. Harbo,et al. The genetics of multiple sclerosis: an up‐to‐date review , 2012, Immunological reviews.
[6] C. Mauri,et al. Immune regulatory function of B cells. , 2012, Annual review of immunology.
[7] G Giovannoni,et al. The evidence for a role of B cells in multiple sclerosis , 2012, Neurology.
[8] D. Saadoun,et al. Vitamine D et auto-immunité. Deuxième partie : aspects cliniques , 2012 .
[9] M. Pender. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis , 2012, Autoimmune diseases.
[10] G. Giovannoni,et al. Association of innate immune activation with latent Epstein-Barr virus in active MS lesions , 2012, Neurology.
[11] G. Giovannoni,et al. Translational Mini‐Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein–Barr virus entry to the central nervous system? , 2012, Clinical and experimental immunology.
[12] B. Becher,et al. T(H)17 cytokines in autoimmune neuro-inflammation. , 2011, Current opinion in immunology.
[13] R. Liblau,et al. Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis , 2011, FEBS letters.
[14] T. Korn,et al. Cytokines and effector T cell subsets causing autoimmune CNS disease , 2011, FEBS letters.
[15] A. Bar-Or,et al. B cells in multiple sclerosis: connecting the dots. , 2011, Current opinion in immunology.
[16] P. Menheere,et al. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission , 2011, Journal of Neuroimmunology.
[17] F. Jadidi-Niaragh,et al. Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis , 2011, Scandinavian journal of immunology.
[18] B. Segal,et al. IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathway , 2011, Brain, Behavior, and Immunity.
[19] S. Audia,et al. Les lymphocytes TH17 : différenciation, phénotype, fonctions, et implications en pathologie et thérapeutique humaine , 2011 .
[20] W. Brück,et al. Intracerebral Human Regulatory T Cells: Analysis of CD4+CD25+FOXP3+ T Cells in Brain Lesions and Cerebrospinal Fluid of Multiple Sclerosis Patients , 2011, PloS one.
[21] R. Mechelli,et al. CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis. , 2011, Brain : a journal of neurology.
[22] Yuhong Yang,et al. Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? , 2011, Biochimica et biophysica acta.
[23] M. Horwitz,et al. Epstein-Barr virus infection of human brain microvessel endothelial cells: A novel role in multiple sclerosis , 2011, Journal of Neuroimmunology.
[24] E. S. St. Clair,et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. , 2011, Blood.
[25] N. Tubridy,et al. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis , 2010, Clinical and experimental immunology.
[26] Nitin J. Karandikar,et al. Memory B cells from a subset of treatment‐naïve relapsing‐remitting multiple sclerosis patients elicit CD4+ T‐cell proliferation and IFN‐γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein , 2010, European journal of immunology.
[27] T. Tedder,et al. Regulatory B Cells (B10 Cells) and Regulatory T Cells Have Independent Roles in Controlling Experimental Autoimmune Encephalomyelitis Initiation and Late-Phase Immunopathogenesis , 2010, The Journal of Immunology.
[28] O. Lantz,et al. Antimicrobial activity of mucosal-associated invariant T cells , 2010, Nature Immunology.
[29] J. Souberbielle,et al. Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? , 2010, Brain : a journal of neurology.
[30] S. Vukusic,et al. Geographic variations of multiple sclerosis in France. , 2010, Brain : a journal of neurology.
[31] J. Goverman,et al. Viral Infection Triggers Central Nervous System Autoimmunity Via Activation of Dual TCR-Expressing CD8+ T Cells , 2010, Nature Immunology.
[32] K. Venken,et al. Disturbed regulatory T cell homeostasis in multiple sclerosis. , 2010, Trends in molecular medicine.
[33] L. Kasper,et al. Multiple sclerosis immunology , 2010, Neurology.
[34] T. Tedder,et al. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer , 2010, Annals of the New York Academy of Sciences.
[35] L. Fugger,et al. Pathogenic CD8+ T cells in multiple sclerosis , 2009, Annals of neurology.
[36] J. Goverman. Autoimmune T cell responses in the central nervous system , 2009, Nature Reviews Immunology.
[37] B. Engelhardt,et al. C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE , 2009, Nature Immunology.
[38] Jianping Jin,et al. Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. , 2009, Clinical immunology.
[39] A. Compston,et al. Multiple sclerosis , 2008, The Lancet.
[40] D. Laplaud,et al. Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis. , 2008, The Journal of clinical investigation.
[41] D. Wraith,et al. Cutting Edge: Th1 Cells Facilitate the Entry of Th17 Cells to the Central Nervous System during Experimental Autoimmune Encephalomyelitis1 , 2008, The Journal of Immunology.
[42] P. Youinou,et al. Regulatory B lymphocytes in humans: a potential role in autoimmunity. , 2008, Arthritis and rheumatism.
[43] R. Reynolds,et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.
[44] H. Lassmann,et al. Multiple sclerosis: T-cell receptor expression in distinct brain regions. , 2007, Brain : a journal of neurology.
[45] Nathalie Arbour,et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.
[46] Roland Martin,et al. Multiple sclerosis: a complicated picture of autoimmunity , 2007, Nature Immunology.
[47] H. Lassmann,et al. Experimental models of multiple sclerosis. , 2007, Revue neurologique.
[48] M. Duddy,et al. Distinct Effector Cytokine Profiles of Memory and Naive Human B Cell Subsets and Implication in Multiple Sclerosis , 2007, The Journal of Immunology.
[49] J. Lünemann,et al. Epstein-Barr virus and multiple sclerosis , 2007, Current neurology and neuroscience reports.
[50] G. Pantaleo,et al. CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis. , 2007, Clinical immunology.
[51] H. Hartung,et al. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis , 2006, Proceedings of the National Academy of Sciences.
[52] T. Mcclanahan,et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.
[53] Clare Baecher-Allan,et al. Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.
[54] M. Barnett,et al. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.
[55] M. Duddy,et al. Distinct Profiles of Human B Cell Effector Cytokines: A Role in Immune Regulation?1 , 2004, The Journal of Immunology.
[56] Shimon Sakaguchi,et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. , 2004, International immunology.
[57] R. Kastelein,et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.
[58] David Gray,et al. B cells regulate autoimmunity by provision of IL-10 , 2002, Nature Immunology.
[59] H. Neumann,et al. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases , 2002, Trends in Neurosciences.
[60] A. Ziegler,et al. Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. , 2002, Brain : a journal of neurology.
[61] H. Neumann,et al. Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. , 2001, The American journal of pathology.
[62] Hans Lassmann,et al. Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction , 2000, The Journal of experimental medicine.
[63] P. Kivisäkk,et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis , 1999, Multiple sclerosis.
[64] Charles A. Janeway,et al. Experimental Autoimmune Encephalomyelitis Induction in Genetically B Cell–deficient Mice , 1996, The Journal of experimental medicine.
[65] R. Hirsch,et al. EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON , 1987, The Lancet.
[66] T. Rivers,et al. OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS , 1933, The Journal of experimental medicine.
[67] A. Minagar. Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis , 2011 .
[68] Jia Newcombe,et al. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. , 2008, The American journal of pathology.
[69] R. Reynolds,et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.
[70] L. Steinman. Erratum: A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.
[71] B. Weinshenker,et al. Multiple sclerosis. , 2000, The New England journal of medicine.
[72] C. Confavreux,et al. [Etiology of multiple sclerosis]. , 1991, La Revue du praticien.
[73] J. Mussini,et al. [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.
[74] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.